Mark Harber
Impact in
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
Papers in
- Epidemiology 14
- Cytomegalovirus and herpesvirus research 8
- Herpesvirus Infections and Treatments 3
-
- Renal Transplantation Outcomes and Treatments 12
- Co-authors
- Claire Atkinson (6 shared papers)Colette Smith (4 shared papers)Paul Griffiths (5 shared papers)Douglas Thorburn (3 shared papers)James O’Beirne (3 shared papers)Sowsan Atabani (3 shared papers)Vincent C. Emery (2 shared papers)P. Sweny (4 shared papers)
- Journals
- Nephrology Dialysis Transplantation (5 papers)PLoS ONE (3 papers)Transplantation (3 papers)Kidney International (2 papers)Kidney International Reports (1 paper)
- Partner nations
- United KingdomEgyptUnited States
In The Last Decade
Mark Harber
52 papers receiving 895 citations
Peers
Comparison fields: 5 of 91
- Transplantation 126
- Nephrology 121
- Epidemiology 301
- Infectious Diseases 131
- Immunology 122
Countries citing papers authored by Mark Harber
This map shows the geographic impact of Mark Harber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harber more than expected).
Fields of papers citing papers by Mark Harber
This network shows the impact of papers produced by Mark Harber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harber. The network helps show where Mark Harber may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Harber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 150 | |
| 2 | 2019 | 51 | |
| 3 | 2022 | 49 | |
| 4 | 2011 | 47 | |
| 5 | 2013 | 39 | |
| 6 | 1999 | 33 | |
| 7 | 2016 | 32 | |
| 8 | 2000 | 32 | |
| 9 | 2021 | 31 | |
| 10 | 2004 | 29 | |
| 11 | UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis. | 2017 | 28 |
| 12 | 2019 | 27 | |
| 13 | 2015 | 27 | |
| 14 | 2015 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2018 | 24 | |
| 17 | 2009 | 23 | |
| 18 | 2018 | 21 | |
| 19 | 2016 | 21 | |
| 20 | 2016 | 18 |
About Mark Harber
Mark Harber is a scholar working on Epidemiology, Transplantation, Infectious Diseases, Nephrology and Pathology and Forensic Medicine, having authored 54 papers that have together received 904 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (12 papers), Cytomegalovirus and herpesvirus research (8 papers), Systemic Sclerosis and Related Diseases (4 papers), Organ Donation and Transplantation (4 papers), Polyomavirus and related diseases (3 papers), HIV/AIDS drug development and treatment (3 papers), Herpesvirus Infections and Treatments (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Transplantation (126 citations), Nephrology (121 citations), Epidemiology (301 citations), Infectious Diseases (131 citations) and Immunology (122 citations). Mark Harber has collaborated with scholars based in United Kingdom, Egypt and United States. Frequent co-authors include Claire Atkinson, Colette Smith, Paul Griffiths, Douglas Thorburn, James O’Beirne, Sowsan Atabani, Vincent C. Emery, P. Sweny, David C. Wraith and Anette Sundstedt. Their work appears in journals such as Nephrology Dialysis Transplantation, PLoS ONE, Transplantation, Kidney International and Kidney International Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.